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Avian bornavirus (ABV) is the presumed causative 
agent of proventricular dilatation disease (PDD), a major 
fatal disease in psittacines. However, the inﬂ  uencing factors 
and pathogenesis of PDD are not known and natural ABV 
infection exhibits remarkable variability. We investigated the 
course of infection in 18 cockatiels that were intracerebrally 
and intravenously inoculated with ABV. A persistent ABV 
infection developed in all 18 cockatiels, but, as in natural 
infection, clinical disease patterns varied. Over 33 weeks, 
we simultaneously studied seroconversion, presence of 
viral RNA and antigens, infectious virus, histopathologic 
alterations, and clinical signs of infection in the ABV-infected 
birds. Our study results further conﬁ  rm the etiologic role of 
ABV in the development of PDD, and they provide basis for 
further investigations of the pathogenetic mechanisms and 
disease-inducing factors for the development of PDD.
P
roventricular dilatation disease (PDD) is a signiﬁ  cant 
cause of disease-related fatalities among birds, primarily 
psittacines (1–3). PDD has been observed in >50 psittacine 
species. Large parrots, including many endangered species, 
are the most frequently and most severely affected birds 
(4). PDD constitutes a threat to all parrot ﬂ  ocks and aviaries 
worldwide and endangers the protection and conservation 
of captive and wild psittacine species.
PPD is caused by a nonpurulent inﬂ  ammation of the 
autonomic nervous system of the upper gastrointestinal 
tract, the peripheral and central nervous tissue, and the 
cardiac conduction system (5,6). Gastrointestinal and 
neurologic signs can appear alone or in combination 
(4,7,8). The clinical signs are nonspeciﬁ  c, and PDD can 
be deﬁ  nitively diagnosed only by pathohistologic detection 
of lymphoplasmacytic inﬁ  ltrates of ganglia in the upper 
gastrointestinal tract. However, a negative ﬁ  nding cannot 
exclude the presence of PDD (4,6,8,9).
In 2008, 2 independent groups of research scientists 
described a new virus, avian bornavirus (ABV), which 
was ampliﬁ  ed from samples from PDD-affected birds. 
Since then, 6 different ABV genotypes have been 
detected in psittacines birds. Additional genotypes have 
been detected in a canary (Serinus canaria), wild Canada 
geese (Branta canadensis), and trumpeter swans (Cygnus 
buccinator) (3,10–12). Recent studies substantiate the 
crucial role of ABV as the etiologic agent for PDD (10,11). 
Several scientiﬁ  c groups found ABV in 60%–100% of 
PDD-affected birds studied (10,11,13–15). Surveillance 
studies in aviaries showed that not all birds were affected 
after exposure to PDD-diseased and ABV-positive birds, 
and clinical signs and infection status varied considerably 
in birds that were affected. In addition, some ABV-
positive birds showed no clinical signs (16–20). These 
facts indicate that host factors as well as features of 
the infectious agent, ABV, play a key role for disease 
induction (18).
Initial studies of experimental infections in birds 
fulﬁ  lled Henle-Koch postulates by using small numbers 
of animals. Gancz et al. (21) inoculated 3 cockatiels by 
multiple routes with brain homogenate containing ABV-
4. Sixty-six days postinoculation (dpi), PDD-associated 
signs, including characteristic histopathologic lesions, 
developed in 2 of the 3 birds, and test results were 
positive for ABV-4. The implications of these ﬁ  ndings 
were obscured by the fact that the brain homogenate 
also included sequences with partial analogy to viruses 
of the family Astroviridae and family Retroviridae. After 
inoculating 4-day-old mallards (Anas platyrhynchos; n 
= 15) with ABV-4, Gray and colleagues (22) detected 
Pathogenesis of Avian Bornavirus in 
Experimentally Infected Cockatiels
Anne K. Piepenbring, Dirk Enderlein, Sibylle Herzog, Erhard F. Kaleta, Ursula Heffels-Redmann, 
Saskia Ressmeyer, Christiane Herden, and Michael Lierz
RESEARCH
234  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 18, No. 2, February 2012
Author afﬁ   liation: Justus Liebig University Giessen, Giessen, 
Germany
DOI: http://dx.doi.org/10.3201/eid1802.111525Pathogenesis of Avian Bornavirus in Cockatiels
ABV RNA in the feces and antibodies against ABV in 
serum, but they did not detect any clinical signs or PDD-
associated lesions. Later, Gray et al. (23) inoculated 2 
adult Patagonian conures (Cyanoliseus patagonis) with 
ABV-4. The conures were known to be chronic carriers 
of psittacine herpesvirus, but they appeared to be healthy. 
Antibodies against ABV were detected 33 dpi, and 
shedding of viral RNA was detected 62 dpi. Clinical PDD 
signs developed in both birds, after which 1 bird died and 
the other was euthanized. Histopathologic analysis showed 
typical PDD lesions. It was not determined whether the 
herpesvirus infection was a potentiating factor (21–23).
Reliable studies that include sufﬁ   cient numbers of 
animals to address the host variability over an adequate 
investigation period are needed to clarify the pathogenetic 
effects of ABV infection on the development of PDD. 
More precisely, this implies the need for investigating the 
course of clinical signs, seroconversion, histopathologic 
lesions, and virus shedding and distribution in the tissues 
of affected birds. To further the understanding of ABV 
and the associated disease, we infected 18 cockatiels with 
ABV by using 2 different inoculation routes and monitored 
them for 33 weeks. Our ﬁ  ndings show that a persistent 
ABV infection was induced by in all 18 birds and that it 
was possible to reliably reproduce all of the known natural 
ABV disease patterns.
Material and Methods
Inoculum and Sequencing
The virus for inoculation was originally isolated from 
the brain of a scarlet macaw (Ara macao) that died from 
PDD; the inoculation was passaged 6 times in the quail 
cell line CEC-32 (24). The persistently ABV-infected 
CEC-32 cells were suspended in medium with 2% fetal 
bovine serum, sonicated, clariﬁ   ed by centrifugation at 
3,000 × g for 10 min, and assayed to determine infectivity. 
For inoculations, we used an infectivity titer of 104 50% 
infectious dose/mL.
By using the RNeasy Mini Kit (QIAGEN, Hilden, 
Germany) according to the manufacturer’s instructions, we 
isolated total RNA for sequencing from 200 μL of virus-
containing supernatant. Total RNA was reverse transcribed 
by using random hexamer primers. PCR for parts of the 
large viral polymerase and the nucleocapsid protein genes 
of avian bornavirus was performed as described (11). We 
analyzed PCR products by using gel electrophoresis and 
puriﬁ  ed the products for sequencing by using the QIAquick 
PCR Puriﬁ  cation Kit (QIAGEN). Sequencing was carried 
out by LGC Genomics (Berlin), and BlastN (http://blast.
ncbi.nlm.nih.gov/Blast.cgi) was used to align generated 
sequence information.
Experimental Infection of Cockatiels
For inoculation purposes, we divided the cockatiels 
into 2 groups (groups ic and iv), each consisting of 9 
animals. We intracerebrally (IC) inoculated birds in group 
ic and intravenously (IV) inoculated birds in group iv with 
0.1 mL of the inoculum described above. All birds were 
under isoﬂ   urane anesthesia when inoculated. One bird 
remained untreated and served as a sentinel bird in group 
ic. Another group of 9 birds from the same ﬂ  ock served as 
controls; they remained untreated and were kept separate 
from the inoculated birds during the investigation period.
Study Design (Sampling, Clinical Investigations, 
and Necropsies)
Over a period of 230 days, we surveyed the birds 
daily to determine their health status. We obtained swab 
samples from the crop and cloaca to test for the presence of 
ABV RNA by using real-time reverse transcription PCR as 
described (10). Cycle thresholds (Ct) >36.0 were considered 
negative (10). Swab samples were obtained every other day 
until all birds of the respective group had ABV-positive 
test results, then specimens were obtained weekly. In 
parallel, once a week we obtained 0.3-mL blood samples 
for indirect immunoﬂ   uorescence assay (IIFA) detection 
of antibodies against ABV, as described (25). For humane 
reasons, we euthanized birds with clinical signs typical of 
PDD (emaciation, undigested seed in the feces, neurologic 
signs) and reduced general condition. All remaining birds, 
including control birds, were euthanized 115 or 116 dpi or 
at the end of the trial (229 or 230 dpi).
We obtained samples of brain, eye, spinal cord, 
ischiadic nerve, adrenal gland, heart, liver, kidney, 
spleen, pancreas, crop, proventriculus, gizzard, intestine, 
pectoral muscle, and skin with feathers from all birds 
that died or were euthanized. For histopathologic analysis 
immunohistochemical testing, and other immunohistologic 
procedures, samples were ﬁ  xed in 5% buffered formalin, 
embedded in parafﬁ  n wax, and used for preparation of 
5-μm sections stained with hematoxylin and eosin. Samples 
from similar organs were frozen fresh for subsequent real-
time PCR to detect ABV RNA. In addition, infectious 
virus was isolated by using samples from brain and retina 
as described (25). To exclude the presence of any other 
infection, we examined samples of blood, liver, and lung 
for bacteria; we used mycological staining to examine 
samples of proventriculus for infection with yeast; and we 
examined samples from all intestinal parts for parasites.
Indirect Immunoﬂ  uorescence Assay
Antibodies against ABV were detected by use of an 
IIFA on persistently Borna disease virus (BDV)–infected 
Madin-Darby canine kidney cells. For the assay, we used a 
1:50 dilution of ﬂ  uorescein isothiocyanate–conjugated goat 
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anti-bird IgG (Bethyl Laboratories, Inc., Montgomery, TX, 
USA), as described (25).
Immunohistochemical Testing
We performed immunohistochemical testing according 
to the avidin-biotin complex method, as described (25,26). 
This method uses a polyclonal rabbit antibody directed 
against the phosphoprotein and the X protein of BDV.
Virus Isolation
For virus isolation, we performed infectivity assays as 
described by Narayan et al. (27) and Herzog et al. (25). 
Organ samples were homogenized, and 10-fold dilutions 
were prepared in GIBCO Glasgow Minimum Essential 
Medium BHK-21 1× (Invitrogen, Paisley, UK) with 10% 
fetal bovine serum. The mixture was then mixed with equal 
volumes of freshly dispersed cells of the quail cell line CEC-
32 and then incubated on Lab-Tek Chamber Slides (Nunc, 
Roskilde, Denmark) for 6 days at 37°C. Virus replication 
was demonstrated by indirect immunoﬂ  uorescence by using 
polyclonal serum specimens, which cross-reacted reliably 
with ABV antigen, from rats experimentally infected with 
BDV (25).
Statistical Analysis
We used the Wilcoxon-Mann-Whitney-test to ascertain 
differences between the IC- and IV-inoculated groups. U 
<11 (critical value with α = 0.005) was considered highly 
signiﬁ  cant for calculated test statistics.
Results
Sequence Analysis
We used BlastN (http://blast.ncbi.nlm.nih.gov/Blast.
cgi) to compare newly generated sequences of parts of 
the nucleocapsid protein and large viral polymerase genes 
with sequences available from GenBank. Both genes 
showed highest accordance (99%) with ABV genotype 4 
(EU781959.1 and FJ002323.1). 
Clinical Observations
During the 230-day investigation period, 5 of the 18 
inoculated birds (3 from group iv and 2 from group ic) 
showed clinical signs typical of PDD: birds iv1 and iv3 had 
gastrointestinal signs, birds ic1 and iv5 showed neurologic 
signs, and bird ic2 had gastrointestinal and neurologic 
signs. In bird ic2, the following signs developed 33, 37, 
and 41 dpi, respectively: general symptoms, e.g., apathy; 
undigested seeds in the feces; and epileptic-like seizures. 
In birds iv3 and iv2, gastrointestinal signs ﬁ  rst became 
obvious 116 and 126 dpi, respectively. In birds iv5 and ic1, 
which were only affected neurologically, signs were ﬁ  rst 
noticed 159 and 199 dpi, respectively.
In addition, birds ic6 and iv2 died suddenly and 
unexpectedly, without obvious signs, 66 and 120 dpi, 
respectively. Three apparently healthy birds from each 
group (birds iv3, iv4, iv7, ic3, ic4, and ic8) were euthanized 
115 or 116 dpi. At the end of the investigation period, 
229 or 230 dpi, the remaining birds (iv1, iv5, iv8, iv9, 
ic5, ic7, and ic9) and the sentinel bird (se1), which all 
appeared clinically healthy, were euthanized (Table 1). The 
control birds were in a good health status during the entire 
investigation period and were euthanized with the other 
birds after 230 days.
Gross Findings and Histopathologic Lesions
Necropsy revealed a dilated proventriculus in 7 of the 
18 inoculated birds (ic1, ic2, ic3, iv1, iv2, iv3, and iv4), 
4 of which had shown signs typical of PDD (Table 2). 
Dilatation of the proventriculus was most severe in bird 
ic2, which had both gastrointestinal and neurologic signs. 
No macroscopic alterations were detected in the remaining 
11 inoculated birds, the sentinel bird, or the 9 control birds.
Histopathologic examination revealed that all infected 
birds and the sentinel bird had mononuclear inﬁ  ltrates 
characteristic of PDD in a wide range of organs and of 
considerable severity. Most of the immune cell inﬁ  ltrates 
were in the central nervous system and the gastrointestinal 
tract, but they were also present in heart; liver; kidney; 
pancreas; skin with feathers; and, in 1 case, the spleen. 
In some of the animals, the inﬁ  ltrates had a follicle-like 
appearance. Inﬁ  ltrates were not detected in the pectoral 
muscle of any birds. No other infections were detected during 
bacteriologic, mycologic, and parasitologic examinations. 
The control group did not have histopathologic alterations 
in organs and did not have any other infection.
Detection of ABV RNA and Antibody against ABV
We detected ABV RNA in swab specimens from all 
inoculated birds and the sentinel bird. We obtained the ﬁ  rst 
positive test results for group ic 19–29 dpi, whereas we 
ﬁ  rst ampliﬁ  ed ABV RNA from group iv samples 25–72 
dpi (Figure 1). By using the Wilcoxon-Mann-Whitney test, 
we determined that ABV RNA was detected signiﬁ  cantly 
earlier in group ic than in group iv (calculated value for test 
statistic U = 5.5, which is <11 [critical value with n1 = 9 and 
n2 = 9] and therefore considered to be highly signiﬁ  cant, 
with α = 0.005). We obtained the ﬁ  rst positive ABV RNA 
test results for the sentinel bird 76 dpi (Figure 1). The Ct 
for all birds constantly decreased during the trial, from 
35.6 at ﬁ  rst ABV RNA detection to 19.8 at last sampling 
(geometric mean values).
Antibodies against ABV were ﬁ  rst detected in group 
ic 7–63 dpi, and group iv birds seroconverted 29–57 dpi 
(Figure 2). Statistical analysis did not show any noticeable 
difference between the ic and iv group (calculated value for 
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test statistic U = 39.5, which is >21 [critical value with n1 = 
9 and n2 = 9] and thus considered not signiﬁ  cant, with α = 
0.05). Antibody titers in groups ic and iv steadily increased 
to <20,480 during the investigation period (Figure 3). We 
did not detect ABV RNA or antibodies against ABV in 
control group birds during the investigation period.
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Table 1. Premortem findings in cockatiels experimentally infected with ABV* 
Bird
Age at 
inoculation,
d/sex
Antibodies against ABV 
RNA‡, first 
detected, dpi
Gastrointestinal signs  Neurologic signs 
Died,
dpi
Euthanized,
dpi
First 
detected, dpi  Titer† 
First 
detected, dpi Titer† 
First 
detected, dpi  Titer† 
ic1 137/F  43  160  27  –  –  199  5,120  –  206 
ic2 121/F  29  20  21  37  320  41  320  –  60 
ic3 137/F  35  320  25  –  –  –  –  –  115 
ic4 137/F  7  20  19  –  –  –  –  –  115 
ic5 121/F  57  320  29  –  –  –  –  –  230 
ic6 137/M  43  1,280  25  –  –  –  – 66  – 
ic7  137/M 63 160 29  –  –  –  –  –  230 
ic8 137/F  43  640  27  –  –  –  –  –  115 
ic9 44/M  7  10  25  –  –  –  – –  230 
iv1 137/F  57  320  71  126  5,120  –  –  –  229 
iv2 137/F  35  160  35  –    –  –  120  – 
iv3  137/M 57 640 43  116  10,240  –  –  –  116 
iv4 137/M  29  40  63  –  –  –  –  –  116 
iv5 121/F  35  640  72  –  –  159  5,120  –  229 
iv6 121/F  43  640  33  –  –  –  –  –  229 
iv7 137/M  35  40  35  –  –  –  –  –  116 
iv8 137/M  35  40  43  –  –  –  –  –  229 
iv9 44/F  29  40  25  –  –  –  – –  229 
se1 137/M  NA  –  76  –  –  –  –  –  230 
*Investigation period was 230 d. ABV, avian bornavirus; dpi, days postinoculation; ic, intracerebrally inoculated; –, not detected or not applicable; iv, 
intravenously inoculated; se, sentinel. 
†Antibodies detected by use of indirect immunofluorescence assay; titers <10.0 are considered negative. 
‡Avian bornavirus RNA detected by real-time reverse transcription PCR as described by Honkavuori et al. (10); cycle thresholds >36.0 are negative.  
Table 2. Postmortem findings in cockatiels experimentally infected with ABV* 
Bird  Died, dpi  Euthanized, dpi  Antibody titer† 
Dilatation of 
proventriculus‡
Antigen detection§ 
Infectious virus¶  p14 p24 
ic1     10,240  2  +  +  + 
ic2 –  206  5,120 3  +  +  + 
ic3 –  60  20,480  1  +  +  + 
ic4 –  115  20,480  0  +  +  + 
ic5 –  115  20,480  0  +  +  + 
ic6 –  230  5,120 0  +  +  + 
ic7 66  –  1,0240 0  +  +  + 
ic8 –  230  1,0240  0  +  +  + 
ic9 –  115  5,120 0  +  +  + 
iv1 –  230  10,240  2  +  +  + 
iv2 –  229  5,120 2  +  +  + 
iv3 120  –  10,240  2 +   +
iv4 –  116  5,120 1  +  +  + 
iv5 –  116  20,480  0  +  +  + 
iv6 –  229  10,240  0  +  +  + 
iv7 –  229  10,240  0  +  +  + 
iv8 –  116  5,120 0  +  +  + 
iv9 –  229  20,480  0  +  +  + 
se1 –  229  <10  0  
*Proventricular dilatation disease was confirmed in all birds by histopathologic confirmation of lymphoplasmacytic infiltrates of/near ganglia in the central 
nervous system and/or upper gastrointestinal tract. ABV, avian bornavirus; dpi, days postinoculation; ic, intracerebrally inoculated; +, positive; , negative; 
iv, intravenously inoculated; se, sentinel. 
†Antibodies against avian bornavirus detected by use of indirect immunofluorescence assay; titers <10.0 are considered negative.
‡0, no dilatation; 1, mild dilatation; 2, moderate dilatation; 3, severe dilatation. 
§Detection of the X-protein (p14) and the phosphoprotein (p24) of Borna disease virus by immunohistochemical testing. 
¶Re-isolation of infectious ABV in quail cell line CEC-32. RESEARCH
Detection of ABV RNA in Organs
We detected ABV RNA in all organs that were 
examined 115 or 116 dpi and 229 or 230 dpi. A high 
amount of ABV RNA (geometric mean Ct 12.0–17.0) 
was found in the central nervous system, gastrointestinal 
tract, and in skin with feathers. Moderate amounts of 
ABV RNA (geometric mean Ct 17.0–23.0) were found in 
heart, kidney, spleen, and pancreas. The lowest amounts 
of ABV RNA (geometric mean Ct 23.0–29.0) were found 
in pectoral muscle and liver. In the sentinel bird, only skin 
with feathers had positive test results (Ct 28.77), but brain, 
crop, gizzard, and intestine had high Ct (>36.0); all other 
organs remained negative for ABV RNA (Figure 4). We 
did not detect ABV RNA in the organs of control birds.
Immunohistochemical Testing
The detection of viral phosphoprotein and X-protein 
was mostly restricted to the central nervous system and the 
heart. In some cases, ABV antigen was also found in some 
parts of the gastrointestinal tract. We detected X-protein 
in all group ic birds but not in the sentinel bird. We could 
not detect phosphoprotein p24 in bird iv3 or in the sentinel 
bird. ABV antigen was not found in any of the organs of 
the control birds.
Virus Isolation
We isolated infectious ABV from all inoculated birds. 
No infectious virus was detected from the organs of the 
sentinel bird or birds in the control group.
Discussion
PPD was ﬁ   rst described in the late 1970s, but its 
etiology remained unknown until 2008 when ABV and 
its correlation to PDD were discovered. Numerous studies 
using naturally infected animals followed this discovery 
and substantiated the close association between ABV 
infection and PDD. This association has been further 
conﬁ  rmed by several experimental trials (21–23,28) that 
used various bird species. However, detailed information 
about the occurrence of clinical signs, seroconversion, 
histologic lesions, viral RNA, and infectious virus using 
a statistically adequate group and sample size was still 
lacking. We reliably and successfully demonstrated these 
details in our study. We reproduced the natural pattern 
of ABV disease variation and the typical signs. We also 
achieved an infection rate of 100%, with the development 
of a persistent ABV infection in all animals, as indicated 
by the constant presence of ABV RNA, ABV antigen, 
infectious virus, and serum antibodies. These results are 
in agreement with other experimental data (21) and with 
infection in birds with natural PDD (18–20,28). 
In our experiments, the discrepancies in infection 
status and in the development of clinical signs in infected 
but clinically healthy birds could be a result of several 
host factors (e.g., age, immune status), virulence, and 
adaption of the inoculated ABV suspension to the cell 
culture. These variations have already been described for 
mammalian BDV infections (29–32). The cockatiels most 
likely had considerable variability in their genetic makeup, 
in contrast, for example, with inbred strains of laboratory 
mice. Such genetic variability could have a substantial 
effect on disease susceptibility. Bird ic2 did show a severe 
progression of clinical signs, and clinical signs developed 
in 4 other cockatiels. This variability in the course of 
ABV infection and development of PDD is similar to the 
variability observed in natural cases of ABV infection (33).
ABV RNA and antibodies to ABV were detected in 
all inoculated birds, and titers of antibody against ABV 
steadily increased during the investigation period; however, 
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Figure 1. Timing of the ﬁ  rst detection of avian bornavirus (ABV) 
RNA in cockatiels that had been intracerebrally or intravenously 
inoculated with ABV. ABV RNA was ampliﬁ  ed signiﬁ  cantly earlier 
in samples from intracerebrally inoculated birds compared with 
intravenously inoculated birds (α = 0.005 by using the Wilcoxon-
Mann-Whitney test). A noninoculated sentinel bird, which was 
housed with the intracerebrally inoculated group of cockatiels, was 
the last bird to shed ABV RNA.
Figure 2. Timing of the ﬁ  rst detection of antibodies against avian 
bornavirus (ABV) in cockatiels that had been intracerebrally or 
intravenously inoculated with ABV. The time of ABV antibody 
detection did not differ substantially between the 2 inoculation 
groups.Pathogenesis of Avian Bornavirus in Cockatiels
these antibodies did not inﬂ  uence the outcome of clinical 
disease. Payne et al. (28) also reported on ABV-infected 
cockatiels in which antibodies to ABV did not inﬂ  uence the 
outcome of clinical disease. Narayan et al. (27) similarly 
reported that in mammals with Borna disease, antibodies 
against ABV do not exhibit protective properties and seem 
not to play a role in immunopathogenesis. Thus, detection 
of antibodies to ABV does not indicate antiviral immunity; 
on the contrary, they indicate a resolved or ongoing ABV 
infection with possible risk for the development of PDD. 
The relevance of these ﬁ  ndings should be considered in the 
diagnosis of possible ABV infections.
We detected ABV RNA considerably earlier in group 
ic than in group iv. This ﬁ  nding agrees with results of 
studies in which rats were experimentally infected with 
BDV and in which the IC route was shown to be the most 
efﬁ  cient route for reproducing the disease; however, it 
was never possible in those studies to infect rats with 
BDV by iv inoculation (27,34). Therefore, the successful 
infection of cockatiels with ABV by IV inoculation 
represents a notable difference between ABV and BDV 
infection. This difference is highlighted by similarities 
in the postinoculation timing of seroconversion and the 
appearance of clinical signs in bird groups iv and ic. 
Gastrointestinal as well as neurologic signs could be noted 
in some birds of both groups. Moreover, we detected 
infectious virus and ABV RNA in all organs of all 
infected birds, whereas BDV exhibits strict neurotropism 
in immune-competent mammals, and spread of the 
virus to peripheral organs is only possible in immune-
incompetent mammals (30,35). Whether this is also the 
case for ABV infection remains unclear. However, in our 
studies, ABV RNA was constantly present at the highest 
levels in the central nervous system and gastrointestinal 
tract, indicating that ABV also has an afﬁ  nity for central 
and peripheral nervous tissue, as previously described 
(13,18,20,21,36). Additional investigations are warranted 
to resolve this issue.
Antibodies to ABV did not develop in the sentinel bird 
(se1) during the investigation period; however, increasing 
amounts of ABV RNA were detected in swab samples from 
the bird beginnning 76 dpi. After Se1 was euthanized, ABV 
RNA was ampliﬁ  ed from the bird’s skin with feathers but 
not from other organs. The presence of ABV RNA in skin 
with feathers might be a result of contamination by virus 
that was constantly shed from other birds in the same cage. 
In contrast, se1 did show lymphoplasmacytic inﬁ  ltrates 
typical for PDD in brain, heart, intestine, or liver. These 
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Figure 3. Avian bornavirus antibody in cockatiels inoculated 
intracerebrally (A) and intravenously (B) with avian bornavirus. In 
both groups, an exponential rise in antibody titers was detected 
within the ﬁ  rst 12 weeks after inoculation and was followed by a 
plateau of high antibody titers (<20,480).
Figure 4. Detection of avian bornavirus (ABV) RNA in different 
tissues from cockatiels that had been intracerebrally or 
intravenously inoculated with ABV and from a noninoculated 
sentinel bird. The geometric mean cycle thresholds (Ct) are shown 
with their respective standard deviations. Ct >36.0 is considered 
negative. Low Ct, implying high amounts of ABV RNA, was detected 
in neuronal and gastrointestinal tissue.RESEARCH
ﬁ  ndings indicate that bird se1 reacted differently than the 
experimentally infected birds, and it may have been more 
efﬁ  cient than the experimental cohort in combatting the 
infection. This might be a result of infection by a different 
route, such as the oral or intranasal route. Additional 
investigations are needed to characterize the effects of 
different infection routes on the outcome of ABV infection 
and the development of PDD. It is already known from 
BDV infection of rats that the route of infection determines 
the severity of disease and that an early up-regulation of 
BDV-speciﬁ  c CD4 T cells can efﬁ  ciently protect against 
infection by the virus (37).
In summary, the experimental infection of cockatiels 
in this study provides reliable evidence that ABV can 
induce a persistent infection by various routes and lead 
to disease patterns similar to those in natural infection. 
Moreover, the etiologic role of ABV for the development 
of PDD was further conﬁ  rmed in an adequately sized 
cohort of cockatiels. Our detailed investigation of 
clinical signs, seroconversion, histopathologic lesions, 
and various viral parameters allowed us to document 
essential data on the course and clinical outcome of ABV 
infections and on the similarities and differences between 
ABV and BDV infections. This will serve as a basis for 
further investigations on the underlying pathogenesis 
and the main contributing virus and host factors in 
ABV infection. It remains to be determined whether 
immunopathologic mechanisms that are based on a T cell–
mediated immune reaction, as known for BDV infection, 
play a role in ABV infection and the development of PDD. 
Findings in the present study add to our understanding 
of the pathogenesis of ABV infection and will facilitate 
interpretation of clinical ﬁ   ndings. Antibodies to ABV 
do not indicate immunity; instead, they point toward a 
resolved or ongoing ABV infection and a possible risk for 
the development of PDD.
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